MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 10 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,839,000 | +11.2% | 3,320,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,552,000 | -8.3% | 3,320,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,783,000 | -9.9% | 3,320,000 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $3,088,000 | -16.4% | 3,320,000 | +13.7% | 0.00% | 0.0% |
| Q3 2016 | $3,694,000 | +43.0% | 2,920,000 | +25.9% | 0.00% | 0.0% |
| Q2 2016 | $2,584,000 | -25.0% | 2,320,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,445,000 | -38.8% | 2,320,000 | -38.9% | 0.00% | -33.3% |
| Q4 2015 | $5,626,000 | -2.5% | 3,800,000 | +3.5% | 0.00% | -25.0% |
| Q3 2015 | $5,773,000 | -22.6% | 3,670,000 | +3.1% | 0.00% | 0.0% |
| Q2 2015 | $7,463,000 | – | 3,560,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|